Indo Us Biotech Limited — Board Meeting, 14-11-2024: Outcome of Board Meeting

The Board of Directors has approved the unaudited financial results for the quarter and half-year ended September 30, 2024. They also authorized an increase in the capital from ₹21 crore to ₹31 crore, along with necessary amendments to the Memorandum of Association. The Board approved a Notice of Postal Ballot and appointed M/s. Amrish Gandhi & Associates as the scrutinizer for the e-voting process to ensure fairness and transparency.